Cite
HARVARD Citation
Tella, S. et al. (2022). An evaluation of ivosidenib for the treatment of IDH1-mutant cholangiocarcinoma. Expert opinion on pharmacotherapy. pp. 1879-1885. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Tella, S. et al. (2022). An evaluation of ivosidenib for the treatment of IDH1-mutant cholangiocarcinoma. Expert opinion on pharmacotherapy. pp. 1879-1885. [Online].